Avenue Solutions

Avenue Solutions filed a Q2 report for Illumina, Inc. on July 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Illumina, Inc. · Sequencing and array-based solutions for genetic research, clinical and applied markets

As filed: AVENUE SOLUTIONS for ILLUMINA, INC.

All filings by Avenue Solutions · Everything Illumina, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to genomic sequencing; H.R. 7118, Genomic Answers for Childrens Health Act of 2026

Trade (domestic/foreign)

General trade issues

Bills named in this filing 1

H.R. 7118
Genomic Answers for Children’s Health Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.